自1957年3月到1976年12月,因涎腺癌住我科手术者共426例,全部经病理复核证实。有405例(95.07%)获得3～22年的随访(失访病例在统计时均按死于肿瘤论)。本文着重分析涎腺癌手术治疗的远期疗效及影响预后的有关因素,并对进一步提高疗效的途径提出初步的探讨。资料本组男性199例,女性227例,年龄3～88 From March 1957 to December 1976, a total of 426 patients with parotid cancer who lived in our department had been confirmed by pathological review. A total of 405 patients (95.07%) were followed up for 3 to 22 years (losing the number of patients who died of oncology in statistics). This article focuses on the analysis of the long-term efficacy of salivary adenocarcinoma surgery and related factors that affect the prognosis, and put forward a preliminary discussion of ways to further improve the efficacy. The data included 199 males and 227 females, aged 3 to 88.